Common Renal toxic drugs and their mode of entering the
tubule and mechanism of toxicity
Drug Name
|
Mode of entry
|
Mechanism
|
Clinical Presentation(s)
|
Tenofivir(TDF)
|
Secreted via the basolateral side via OAT and then enters lumen via
MRP2 in the urine.
|
Mitochondrial dysfunction
|
ATI
Proximal tubulopathy Diabetes Insipidus(rare) |
Gentamicin(Aminoglycosides)
|
They are all filtered and they are attracted to negative
phospholipids and bind to megalin cubulin receptor and enter the cell.
|
Lysosomes binding and then cause mitochondrial damage and tubular
injury—myelin bodies
|
ATI
Bartter’s syndrome( via activating of the CaSR in the TAHL)
Fanconi syndrome(rare)
|
Polymixin
|
All filtered, punch holes enter cells via organic cationic
transporter(OCT) on apical surface
|
Apoptosis and necrosis
|
ATI
|
Vancomycin
|
Unclear how it enters
|
Complement activation
Activation of reactive oxygen species
Mitochondrial injury
Vancomycin cast formations
|
ATI
Worse when combined with Piperacillin / Tazobactam
|
Amphotericin B
|
Unclear how it enters
|
Principal cell defect via holes in the apical membrane
|
Distal hypokalemic RTA
ATI
Hypomagnesemia
Nephrogenic DI |
Heta-Starch, Dextran, Sucrose, Mannitol
|
Filtered and enter proximal cell – pinocytosis and build up and swell
up cells. Cannot be metabolized
|
Osmotic nephrosis
|
ATI
|
Atazanavir
|
Minimal renal excretion, poorly soluble in urinary ph- leading to crystallization
|
Crystal formation
|
Crystal Nephropathy
|
Cisplatin
|
Enters via OCT on the basolateral side, enters and activates
apoptosis
|
Oxidative stress
|
ATI
Hypomagnesemia
Proximal tubulopathy
Salt wasting nephropathy
Nephrogenic DI |
Ifosfamide
|
Enters proximal tubular cell via OCT on the basolateral side and then
metabolized to its metabolized that causes the damage
|
Increased oxidative stress and mitochondrial injury
|
ATI
Fanconi syndrome
|
No comments:
Post a Comment